Country Report Card

Algeria

Total population, 2018 (UN Population Division) 42,228,408
Surviving Infants (surviving to 1 year per year), 2018 (UN Population Division) 1,001,810
Child mortality rate (deaths < 5 years per 1000 live births), 2018 (Global Health Observatory) 23.5
Gross National Income (per capita, current US$), 2017 (World Bank) 3,960
No. of districts/territories, 2018 (JRF) 273
Total expenditure on health per capita (PPP Intl $), 2015 (Global Health Observatory) 1,031
Gov. exp. on Routine Immunization (US$), 2017 (JRF) 126,156,794
country flag

COUNTRY DATA

Algeria

COMMITMENTS INDICATORS 2015 2016 2017 2018 2019 2020
Governance Is the NITAG fully functional? Data not available Data not available Data not available Yes Yes No
Has the country established a NITAG? Data not available Data not available Data not available Yes Yes Yes
Domestic funding Government domestic funding for health as % of GDP 4.98 0.00 0.00 0.00 0.00 0.00
Government funding as % of total immunization funding 100.00 100.00 100.00 100.00 0.00 0.00
Equity Has the country reported district-level stock-out of the DTP or MCV vaccine? No No No No Data not available Data not available
Does the country conduct vaccine impact assessments for at least one newly-introduced vaccine? Data not available Data not available Data not available No Data not available Data not available
Proportion of districts with 80% or more MCV1 coverage 18.00 18.00 17.00 11.00 0.00 0.00
Proportion of districts with 80% or more DTP3 coverage 18.00 18.00 18.00 18.00 0.00 0.00
Effectiveness and efficiency Has the country sustained DTP3 coverage of 90% or more for at least 3 years? (2017-2019) Yes
Has the country sustained MCV1 coverage of 90% or more for at least 3 years? (2017-2019) No
Has the country sustained DTP3 coverage of 90% or more for at least 3 years (2018-2020)? No
Has the country sustained MCV1 coverage of 90% or more for at least 3 years (2018-2020)? No
Surveillance Non-measles febrile rash illness rate 0.10 0.09 0.21 0.10 0.00 0.20
NP-AFP rate 1.45 5.69 6.87 5.23 5.34 2.57
Coverage and VPD elimination DTP1 coverage 99.00 96.00 95.00 96.00 96.00 0.00
DTP3 coverage 95.00 91.00 91.00 91.00 91.00 0.00
MCV1 coverage 95.00 94.00 88.00 80.00 80.00 0.00
MCV2 coverage 99.00 96.00 92.00 77.00 77.00 0.00
OPV3 coverage 95.00 91.00 91.00 91.00 91.00 0.00
IPV1 coverage 8.00 94.00 92.00 94.00 94.00 0.00
Has the country introduced HPV vaccine? No No No No No No
Has the country introduced the Hepatitis B birth dose? Yes Yes Yes Yes Yes Yes
Has the country eliminated MNT? Yes Yes Yes Yes Yes Yes
Has the country eliminated Measles? No
Progress on polio Polio transition plan submitted? No
Did the country have any cases of WPV or cVDPV from 2015-2018? No
Did the country have any cases of WPV or cVDPV in 2019? No
Did the country have any cases of WPV or cVDPV in 2020? No
cVDPV cases 0.00 0.00 0.00 0.00 0.00 0.00
Immunization research Does the country have immunization research activities within the current cMYP? (2020) Data not available
Does the country currently have a comprehensive Multi-Year Plan (cMYP) for immunization? (2020) Data not available
Advocacy and political will Did the country observe African Vaccination Week or World Immunization Week? Data not available Data not available Data not available Data not available
Vaccine development and production Does the country currently manufacture vaccines? Yes
Has the country committed to manufacture vaccines in the next 5 years? Yes
Does the country have a national strategy or plan to manufacture vaccines? Yes
Has the country committed to vaccine manufacturing at the highest level? Yes
Has the country established (and/or is working to establish) a tech transfer hub? Yes
Has the country set aside funding specifically for local manufacture of vaccines? Yes
Does the country have regulatory capacity at level 3 or higher, sufficient to oversee vaccine manufacturing? No
Met Target  
Approaching Target  
Off Target  
No Report